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You	can	publish	open	access,	but	‘big’	journals	still
act	as	gatekeepers	to	discoverability	and	impact
One	of	the	proposed	advantages	of	open	access	publication	is	that	it	increases	the	impact	of	academic	research	by
making	it	more	broadly	and	easily	accessible.	Reporting	on	a	natural	experiment	on	the	citation	impact	of	health
research	that	is	published	in	both	open	access	and	subscription	journals,	Chris	Carroll	and	Andy	Tattersall,
suggests	that	subscription	journals	still	play	an	important	role	in	making	research	discoverable	and	useful	and	thus
still	have	a	role	to	play	even	in	open	publication	strategies.
	
‘Sometimes	you	have	to	do	what	you	don’t	like,	to	get	to	where	you	want	to	be.’	
Tori	Amos
We	recently	completed	a	citation	analysis	of	10	years	of	randomised	controlled	trials	published	by	the	UK	National
Institute	of	Health	Research	(NIHR).	The	biggest	public	funder	of	trials	in	the	UK	produces	their	own	monograph
series,	the	wholly	open-access	Health	Technology	Assessment	(HTA)	journal	and	we	wanted	to	analyse	the	reach
and	impact	of	these	works	when	republished	in	subsequent	commercial	journals.	Such	trials	cost	a	great	deal	of
money,	so	there	is	a	clear	interest	in	determining	the	impact	of	this	research.
Impact	can	of	course	be	assessed	in	many	ways,	but	we	decided	to	assess	the	health	policy	impact	of	these	trials
using	citation	analysis,	by	looking	at	how	many	times	they	were	cited	in	key	policy	documents,	or	types	of	research
that	are	known	to	inform	policy,	that	is	systematic	reviews	and	meta-analyses.	We	also	looked	closely	at	how	the
trials	were	used	in	these	documents.	After	all,	trials	are	conducted	to	help	decision-making	by	health	professionals
and	policy-makers.	They	need	to	be	easily	discoverable	and	useful.	
The	sample	was	133	trials	published	by	the	NIHR	from	2006	to	2015.	As	noted	above,	these	trials	were	all
published	in	the	NIHR’s	own	open-access	HTA	journal	(a	model	of	making	publicly-funded	research	available	to	the
public	since	its	first	volume	in	1997).	The	HTA	monograph	is	a	peer-reviewed	journal	with	each	issue	dedicated	to	a
single	project	–	such	as	a	randomised	controlled	trial	–	and	contains	the	full	report	of	each	trial.	This	might	include
not	only	the	trial’s	effectiveness	findings,	but	also	an	economic	evaluation	and,	in	some	cases,	additional	but
related	work,	such	as	a	qualitative	study.	These	separate	elements	of	the	project	might	also	be	published	in	other
peer-reviewed	journals,	which	have	paywalls	and	more	restrictive	word-counts,	but	also	have	the	potential	to
increase	the	visibility	and	discoverability	of	the	research.
Some	of	the	trials	published	in	our	sample	(82/133)	had	elements	of	the	trial	research	published	separately	in
traditional	‘subscription’	journals,	such	as	The	Lancet	and	the	British	Medical	Journal	(BMJ).	These	are	the	‘big’
journals	in	medicine	and	public	health	with	massive	readerships	and	impact	factors	(from	around	‘25’	to	‘60’,
compared	to	approximately	‘4	or	5’	for	the	HTA	journal).	When	conducting	the	analysis,	we	included	these
additional	publications	of	the	trials	in	the	‘impact’	assessment.
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The	citation	analysis	findings	for	these	additional	publications	outstripped	the	impact	numbers	for	the	HTA	journal.
We	found	that	these	related	publications	achieved	twice	the	mean	number	of	citing	reviews	and	more	than	four
times	the	mean	number	of	citing	policy	documents	than	the	HTA	journal	publication:	125	vs	25	citations	per	trial;
7.16	vs	3.32	reviews	per	trial;	3.59	vs	0.80	policy	documents	per	trial.	These	additional	publications	therefore
appeared	to	generate	much	larger	numbers	of	key	citations,	in	policy	documents	and	reviews,	compared	with	their
equivalent	HTA	journal	publications.
So,	can	we	conclude	that	the	additional	publication	of	elements	of	these	trials	in	subscription	journals,	including
possibly	paying	their	open	access	charges,	enhanced	their	impact?	Well,	not	really.	Good	quality	research	and
guidance	documents	should	have	found	the	HTA	publication	and	its	data	anyway	(a	proportion	cited	both	the	HTA
and	its	additional	publication).	A	direct	comparison	of	citation	data	to	answer	this	question	unequivocally	is	not
possible.	However,	the	numbers	for	the	additional	publications,	including	unique	citations	in	policy	documents,	are
large	enough	to	be	compelling.	
Publishing	trial	data	in	big	journals	such	as	The	Lancet	and	BMJ	might	make	the	data	far	more	‘discoverable’,	and
thus	enhance	the	potential	impact	of	publicly-funded	research.	There	might	therefore	be	value	for	researchers,
policy-makers	and	the	public	in	a	publishing	model	that	combines	full	open-access	publication	(a	must	for	publicly-
funded	research,	surely)	with	selective	additional	publication	in	certain,	select,	influential	subscription	journals	(while
being	aware	that	‘salami	slicing’	publication	strategies	do	not	necessarily	represent	‘good	practice’).	Indeed,	public
funders	could	maintain	their	own	lists	of	appropriate	journals	for	publication	of	their	research,	in	addition	to	the
open-access	versions,	though	of	course,	for	some,	that	raises	questions	concerning	academic	freedom.	Of	course,
the	ideal	would	be	for	funders	to	develop	their	own	high-impact,	wholly	open-access	journals	that	can	compete	with
the	‘big’	journals	but,	even	if	this	could	be	realised,	it	is	a	way	off.	In	the	meantime,	public	funders	of	research
should	very	selectively	exploit	the	system	that	is	there,	by	‘using’	the	publishers	(and	certain	journals	only).	This	is
an	arguably	a	novel	‘reversal’	of	the	current	perceived	relationship	between	publishers	and	academics,		where	the
author	supplies	what	is	in	effect	‘second	hand’	content	to	be	considered	by	the	journal.	In	normal	circumstances,
such	works	could	be	declined	due	to	the	publisher	not	having	first	access	to	the	research.	Yet	it	is	the	high
intellectual	value	of	these	works	that	not	only	ensures	they	are	published	again,	but	they	are	given	a	place	in	high
impact	journals.	
	
Readers	can	find	the	full	analysis	and	findings	of	Chris	and	Andy’s	study	are	here.
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Note:	This	article	gives	the	views	of	the	authors,	and	not	the	position	of	the	LSE	Impact	Blog,	nor	of	the	London
School	of	Economics.	Please	review	our	comments	policy	if	you	have	any	concerns	on	posting	a	comment	below
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